M Banaji
Overview
Explore the profile of M Banaji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baptist E, Banaji M
Pediatr Rev
. 1999 Oct;
20(10):353, 354-5.
PMID: 10512891
No abstract available.
2.
Bowden R, Slichter S, Sayers M, Weisdorf D, Cays M, Schoch G, et al.
Blood
. 1995 Nov;
86(9):3598-603.
PMID: 7579469
We performed a prospective, randomized trial in CMV seronegative marrow recipients to determine if filtered blood products were as effective as CMV-seronegative blood products for the prevention of transfusion-transmitted CMV...
3.
McDonald G, Hinds M, Fisher L, Schoch H, WOLFORD J, Banaji M, et al.
Ann Intern Med
. 1993 Feb;
118(4):255-67.
PMID: 8420443
Objective: To determine the incidence and clinical course of veno-occlusive disease of the liver (VOD) after bone marrow transplantation and to analyze risk factors for severe VOD. Design: Cohort study...
4.
Sullivan K, Meyers J, Petersen F, Bowden R, Counts G, Banaji M, et al.
Haematol Blood Transfus
. 1990 Jan;
33:539-45.
PMID: 2182446
It is now almost 2 decades after the first successful human marrow transplants from HLA-identical siblings for the treatment of life-threatening hematologic diseases. Results have improved, especially for patients transplanted...
5.
Bensinger W, Petersen F, Banaji M, Buckner C, Clift R, Slichter S, et al.
Bone Marrow Transplant
. 1989 Jul;
4(4):409-14.
PMID: 2673461
This retrospective study analysed factors affecting engraftment and transfusion requirements of platelets and red blood cells in 303 patients transplanted for acute non-lymphocytic leukemia in first remission from HLA-identical or...
6.
Sullivan K, Storb R, Buckner C, Fefer A, Fisher L, Weiden P, et al.
N Engl J Med
. 1989 Mar;
320(13):828-34.
PMID: 2648143
The occurrence of graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation for leukemia is thought to decrease the probability of recurrence. To study this effect (called adoptive immunotherapy) we modified...
7.
Anasetti C, Rybka W, Sullivan K, Banaji M, Slichter S
Blood
. 1989 Mar;
73(4):1054-8.
PMID: 2920206
Persistent thrombocytopenia after allogeneic marrow transplantation is associated with poor patient survival. To identify the mechanisms of the thrombocytopenia, we studied platelet and fibrinogen kinetics and antiplatelet antibodies in 20...
8.
Bensinger W, Buckner C, Clift R, Williams B, Banaji M, Thomas E
Transplant Proc
. 1987 Dec;
19(6):4605-8.
PMID: 3321630
No abstract available.
9.
Bowden R, Sayers M, Gleaves C, Banaji M, Newton B, Meyers J
Transfusion
. 1987 Nov;
27(6):478-81.
PMID: 2825381
The authors report 2.5 years' experience with the use of cytomegalovirus (CMV)-seronegative blood components for the prevention of primary CMV infection after allogeneic marrow transplantation from seronegative marrow donors to...
10.
Clift R, Buckner C, Thomas E, Kopecky K, Appelbaum F, Tallman M, et al.
Bone Marrow Transplant
. 1987 Oct;
2(3):243-58.
PMID: 3332174
The results are presented of allogeneic transplantation for 363 patients with acute non-lymphoblastic leukemia treated in Seattle from May 1973 through December 1985. The probabilities of surviving disease-free for 5...